{"article_title": "HIV Coinfection Section of the Adult and Adolescent Antiretroviral Treatment Guidelines Released", "article_keywords": ["viral", "hcv", "hiv", "adolescent", "hepatitis", "drugs", "antiretroviral", "guidelines", "disease", "coinfection", "released", "treatment", "table", "arv", "adult"], "article_url": "https://blog.aids.gov/2014/11/revised-hepatitis-c-hcvhiv-coinfection-section-of-the-adult-and-adolescent-antiretroviral-treatment-guidelines-released.html", "article_text": "Last week, the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents announced the release of the updated \u201cGuidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents.\u201d As described in What\u2019s New in the Guidelines, this interim revision of the guidelines features a revised section on Hepatitis C (HCV)/HIV Coinfection that emphasizes considerations for use of antiretroviral (ARV) drugs in patients who also receive treatment for HCV infection. The section includes a new table (Table 12) that provides clinicians with guidance on the concomitant use of HCV drugs and ARV drugs with a focus on potential pharmacokinetic drug interactions.\n\nTo view or download the guidelines, go to the Adult and Adolescent ARV Guidelines section of NIH\u2019s AIDSinfo. Separate PDF files that include only the guideline tables or boxed recommendations can also be downloaded from the page.\n\n\u201cGiven the quickly evolving HCV therapy arena, timely updates to the HCV/HIV Coinfection section of the Antiretrovial Treatment Guidelines help ensure that HIV care providers are well-equipped to take full advantage of new therapeutic options. Such provider resources are an important part of implementing the national Viral Hepatitis Action Plan as we work to improve testing, care, and treatment of viral hepatitis to prevent liver disease and cancer,\u201d noted Corinna Dan, R.N., M.P.H., the Viral Hepatitis Policy Advisor in the HHS Office of HIV/AIDS and Infectious Disease Policy. \u201cUsing the newly approved HCV therapies is highly effective in curing coinfected patients of their HCV and can reduce deaths due to liver disease, one of the leading causes of death among people living with HIV/AIDS.\u201d", "article_metadata": {"og": {"site_name": "blog.aids.gov \u2014 HIV Policy & Programs. Research. New Media.", "description": "Last week, the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents announced the release of the updated \u201cGuidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents.\u201d As described in What\u2019s New in the Guidelines, this interim revision of the guidelines features a revised section on Hepatitis C (HCV)/HIV Coinfection that emphasizes...", "title": "Revised Hepatitis C (HCV)/HIV Coinfection Section of the Adult and Adolescent Antiretroviral Treatment Guidelines Released", "url": "https://blog.aids.gov/2014/11/revised-hepatitis-c-hcvhiv-coinfection-section-of-the-adult-and-adolescent-antiretroviral-treatment-guidelines-released.html", "image": "https://blog.aids.gov/wp-content/uploads/211.jpg", "type": "article"}, "article": {"section": "HIV Policy & Programs", "tag": "NIH,PLWHA,Treatment,Viral Hep Action Plan"}, "viewport": "width=device-width, initial-scale=1, maximum-scale=1"}, "_id": "\"57477af36914bd0286fd3bad\"", "article_summary": "To view or download the guidelines, go to the Adult and Adolescent ARV Guidelines section of NIH\u2019s AIDSinfo.\nThe section includes a new table (Table 12) that provides clinicians with guidance on the concomitant use of HCV drugs and ARV drugs with a focus on potential pharmacokinetic drug interactions.\n\u201cGiven the quickly evolving HCV therapy arena, timely updates to the HCV/HIV Coinfection section of the Antiretrovial Treatment Guidelines help ensure that HIV care providers are well-equipped to take full advantage of new therapeutic options.\nLast week, the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents announced the release of the updated \u201cGuidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents.\u201d As described in What\u2019s New in the Guidelines, this interim revision of the guidelines features a revised section on Hepatitis C (HCV)/HIV Coinfection that emphasizes considerations for use of antiretroviral (ARV) drugs in patients who also receive treatment for HCV infection.\nSeparate PDF files that include only the guideline tables or boxed recommendations can also be downloaded from the page."}